Stuart Gitlow
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Stuart Gitlow | |
|---|---|
| Born | New York City, New York, U.S. |
| Nationality | American |
| Alma mater | University of Pittsburgh School of Public Health Massachusetts Institute of Technology University of Rhode Island Mount Sinai School of Medicine |
| Scientific career | |
| Institutions | University of Utah Geisel School of Medicine |
Stuart Gitlow (born November 29, 1962) is a general, forensic, and addiction psychiatrist and Past President of the American Society of Addiction Medicine.[1]
Biography
Gitlow was born on November 29, 1962. Following completion of his bachelor of science degree from the Massachusetts Institute of Technology, he earned an M.D. from Mount Sinai School of Medicine, a Master of Public Health degree from the University of Pittsburgh and Master of Business Administration degree from the University of Rhode Island (Beta Gamma Sigma). His psychiatric and public health training were at the University of Pittsburgh Medical Center and Harvard University for his forensic fellowship.[2]
Gitlow has held a number of prominent professional positions in the medicine and public health communities. He served as medical expert to the Social Security Department's Office of Hearings Operations,[citation needed] President of the American Society of Addiction Medicine,[1] American Society of Addiction Medicine delegate to the American Medical Association,[3] and Chair of the American Medical Association Council on Science and Public Health.[4]
According to the Centers for Medicare and Medicaid Services, Gitlow has received more than US $65,000 in funding since 2013. This includes more than US $16,000 in consulting payments from Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson.[5] He has also received more than $43,000 in fees for consulting with multiple pharmaceutical firms including Kaleo, Inc, makers of the opioid overdose antidote Evzio (Naloxone HCl injection); Reckitt Benckiser, makers of Suboxone; and Orexo, makers of the opioid products Abstral (Fentanyl) and Zubsolv (Buprenorphine/naloxone).[5]
Politics
Gitlow has twice unsuccessfully sought election to the Rhode Island General Assembly as representative for Woonsocket, Rhode Island district 49.[6]
On March 17, 2018, Gitlow's private residence and separate medical office were searched by the FBI as part of an investigation.[7]
References
- ^ a b "Biography - Dr Stuart Gitlow". Archived from the original on 2019-01-13. Retrieved 2019-01-12.
- ^ "Stuart Gitlow, MD, MPH, MBA, DFAPA". American Society of Addiction Medicine . Retrieved 2014-07-30.
- ^ "Excessive Video Gaming May Not Be An Addiction". Emaxhealth.com. 2007-06-26. Retrieved 2011-02-01.
- ^ https://www.asam.org/docs/default-source/pressreleases/michael-miller-elected-to-ama-council-of-science-and-public-health_2014-06-16_.pdf [bare URL PDF]
- ^ a b "Physician Profile - Open Payments Data - CMS | CMS Open Payments Data". OpenPaymentsData.CMS.gov. Retrieved 2020-08-14.
- ^ Woonsocket Patch article, Sept. 5, 2012
- ^ "City doctor's home, office raided by FBI". 19 March 2018.
| International | |
|---|---|
| National | |
- Geisel School of Medicine faculty
- Information architects
- Physicians from New York City
- University of Pittsburgh School of Public Health alumni
- Harvard Medical School people
- Living people
- 1962 births
- Massachusetts Institute of Technology alumni
- University of Rhode Island alumni
- American psychiatrists
- University of Utah faculty
- Icahn School of Medicine at Mount Sinai alumni
- Cannabis law reform in the United States